Company
Affinavix
Also known as Affinivax
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Affinivax was aqcuired by GSK in August 2022. Pioneering the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines.
About the company
- Status notes
- Affinivax was aqcuired by GSK in August 2022.
Exit
- Acquisition
- 2022-08
Loading relationship preview